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In yeast, revertants were selected from four respiratory deficient mutants carrying mutations in the cytochrome coxidase subunit I gene. Intragenic 
second site mutations revealed amino acids which are functionally complementary to the original mutated position and may be in topological 
interaction with it. The results provide additional data in favour of the model proposed for the structure of the binuclear centre in proton-motive 
oxidases. 
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1. INTRODUCTION 
Cytochrome c oxidase, the terminal acceptor of the 
mitochondrial respiratory chain, catalyses the reduction 
of oxygen into water. Electron transfer from cyto- 
chrome c to oxygen catalysed by this enzyme is coupled 
to translocation of protons across the membrane. The 
yeast mitochondrial cytochrome oxidase composed of 
up to 13 subunits [l] and containing two haems and two 
copper atoms is a member of a large family of proton 
pumping oxidases [2] which includes oxidases from bac- 
teria, plants and animals. Only three subunits (subunits 
I, II and III), mitochondrially encoded, appear to be 
constituents of the minimal catalytic core and are ho- 
mologous to the subunits of the prokaryote enzymes. 
Subunit I is very highly conserved and has 12 trans- 
membrane helices as predicted from hydropathy analy- 
ses. It contains the ligands for haem a and the binuclear 
centre, haem a&uB. Three-dimensional models for the 
structure of subunit I have been made on the basis of 
sequence comparisons, biophysical data and the assign- 
ment of the histidine ligands to the metal prosthetic 
groups [3-8]. In a recent model [III, the binuclear centre 
is located at about the same level as haem a, near the 
outer positive side of the membrane. A proton channel 
connects the redox centres to the negative aqueous 
phase. Subunit II, essential for catalytic activity, has 
two transmembrane spans and a large hydrophilic do- 
main which contains the ligands of the Cu, and the 
docking site for the cytochrome c [8]. Subunit III does 
not contain redox active centre and appears not to be 
essential for the activity [9] although it may have a role 
in assembly, stability or activity modulation. 
Respiratory deficient mutants with optically detecta- 
ble cytochrome c oxidase, considered most interesting 
in bioenergetics tudies, have been isolated in recent 
studies using Succharomyces cerevisiae ([ 10,111, and un- 
published data). These have identified a large number 
of mutants in the catalytic subunits I, II and III. The use 
of a strain lacking all mitochondrial DNA introns to 
generate mutants [lo] and rapid spectrophotometric 
techniques, which allowed high quality spectra of whole 
cells grown on appropriate media, have been very effec- 
tive [l 11. Genetic analyses and sequencing have been 
able to identify the nucleotide changes and the resulting 
amino acid replacements responsible for the deficiency 
in several mutants of subunit I [lo]. 
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In the present work, four deficient mutants, L13, L29, 
L45 and L53, with known nucleotide substitution [lo] 
(Fig. 1) in the subunit I encoding gene, were chosen for 
the reversion analyses. The search for intragenic rever- 
sions of deficient mutations is a fruitful approach in 
order to identify amino acid replacements compatible 
with the function of the enzyme. Distant reversions 
allow the detection of pairs of amino acids which are 
functionally complementary and potentially close in 
space. Mutant L13 (G253D) with a glycine to aspartate 
change in position 253 located in the transmembrane- 
spanning helix 6, in the vicinity of the Cue ligand, histid- 
ine-241, is likely to carry a limited topological alteration 
restricted to the binuclear centre environment since it 
still has optically detectable cytochrome oxidase and 
shows a significant faster CO recombination kinetics 
compared to the parental strain [ 111. This change, how- 
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ever, leads to a total inability of yeast to grow on glyc- 
erol. Mutant L29 (T316K), with a threonine to lysine 
change in position 316 located in the cc-helix 8, has 
optically detectable cytochrome oxidase and is similarly 
affected in the CO recombination kinetics. In contrast 
to L13, it grows poorly on glycerol indicating a partial 
cytochrome oxidase activity. This CO recombination 
effect may indicate, as suggested by Brown et al. [7,11], 
that helix 8 and position 316 are also located in the 
binuclear centre environment or in the channel leading 
to it from the negative aqueous phase. Mutant L53 
(G352V), carrying a glycine to valine mutation in posi- 
tion 352 located in helix 9 has an optically detectable 
cytochrome oxidase and shows no modification of the 
CO recombination kinetics [l 11. Like L29 (T3 16K), this 
mutant has a weak growth on glycerol. Mutant L45 
with a replacement of aspartate to asparagine (D369N) 
in position 369 located in the extramembranous loop 
between helices 9 and 10, has no optically detectable 
cytochrome oxidase and is totally unable to grow on 
glycerol. The mutated position is included in a sequence 
of seven well conserved amino acids which might be 
involved in intersubunit electron transfer between CuA 
in subunit II and haem u in subunit I [7]. It is also 
separated by seven amino acids from histidine-376 
which is the ligand of haem a, in the binuclear centre. 
2. MATERIALS AND METHODS 
2.1. Strains and media 
The strains are described in [lo]. Revertants were selected from the 
mutants L13, L29, L45 and L53, after transfer of the mutant mito- 
chondhal genome in the nuclear context of W303-1B. The yeasts were 
grown in glucose medium (YD: 1% yeast extract, 3% glucose) or 
glycerol medium (YG: 1% yeast extract, 3% glycerol). 
2.2. Selection of revertants 
The Mit- mutants are unable to grow on glycerol medium. Sponta- 
neous revertants (mbpiratory competent clones) can easily be obtained 
after selection on glycerol medium. For increased frequencies of rever- 
tams, treatments using MnCl,, a Mit DNA mutagen were performed. 
From each Mit- mutant, 50-100 single colonies grown on glucose 
medium were plated on glycerol medium to obtain a lawn of about IO* 
cells. A small number of respiratory competent colonies appeared 
after one to three weeks of incubation at 28°C. One revertant per 
mutant colony was picked up and subcloned. Mutagenesis was per- 
formed on 10’ cells per ml in glucose medium with 8 mM of MnCl, 
during 6 h. After mutagenesis, the cell suspension was spread on 
glycerol medium. After one to three weeks of incubation at 28”C, 
revertants appeared and were picked up and subcloned. For large 
numbers of independent reatments, 96-well microtiter plates were 
used. Treatments were performed in the same conditions as described 
above and only one revertant per mutagenesis was picked up and 
subcloned. The selection of revertants from L29 and L53 was done at 
22°C. At this temperature, the mutants did not grow on glycerol 
whereas at 2PC, they ‘showed a weak growth on glycerol. 
3. RESULTS AND DISCUSSION 
The revertants derived from the mutant L13 (G253D) 
were directly seq,uenced. For the revertants selected 
from L29 (T316K), L53 (G352V) and L45 (D369N), the 
mitochondrial heredity of the reversion was determined 
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Fig. 1. Localisation of the amino acid substitutions in the folding 
model of the cytochrome oxidase subunit I. Only the helices 5 to 10 
were presented. The histidine ligands of the haems a and a, and of the 
Cu, are represented by the squares. Histidines 2,3 and 4 are thought 
to be the ligands of Cu,; histidine 5, the ligand of haem a,; histidine 
6, one of the haem a ligands. The deficiency mutations G253D (L13), 
D369N (L45), T3 16K (L29) and G352V (L53) are in bold letters. Their 
distant reversions are indicated by arrows. 
as described in [12] before sequencing. Mutations were 
sequenced directly on DNA segments amplified by 
asymmetrical polymerase chain reaction [lo]. The cor- 
relation between the deficiency expressed in the mutants 
and the nature and position of their mutations found in 
the nucleotide sequence is confirmed by the production 
of wild type reversions, i.e. the restoration of the wild 
type nucleotide sequence. Only with mutant L29, wild 
type reversions were not found. But the location of the 
deficiency mutation in L29 was confirmed within a re- 
gion of about 400 nucleotides by genetic mapping using 
discriminating deletion mutants (petite mutants). This 
region was entirely sequenced and no other change ex- 
cept in codon 3 16 was found. Non-wild-type reversions 
are presented in Table I. 
The same second site amino acid replacements were 
observed in genetically independent revertants (Table I) 
and the sequencing data were confirmed by the genetic 
localisation of the reversions by petite mapping [ 121 and 
by analysis of the genetic recombination frequencies in 
diploid progeny issued from the crosses between the 
revertants and the wild type strain (data not shown). 
Therefore, the observed distant mutations were consid- 
ered as responsible for the restoration of the respiratory 
competence. 
No distant reversions have been found so far for the 
mutant L13 (G253D). All the reversions affect the same 
codon in position 253: in 16 revertants, the aspartate 
was replaced by an asparagine (G > D > N) and in 2 
revertants, by an alanine (G > D > A). The replacement 
of aspartate to asparagine leads to a charge change and 
the amino acid remains significantly larger than the wild 
type glycine whereas the reversion to alanine reduces 
the size of the amino acid. 
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Only distant reversions of L29 mutation (T316K) 
were found among the 21 revertants. Three changes 
were located in the loop between helices 6 and 7: in 
position 267, a valine was replaced by a methionine or 
by a leucine (V267M and V267L); in position 256, a 
serine was replaced by a threonine (S256T). These re- 
sults add data in favour of functional and structural 
relations between helices 6, 7 and 8 as proposed by the 
model of Brown et al. [7]. Other reversions include posi- 
tion 184, at the bottom of helix 5, where a leucine was 
changed in a phenylalanine (L184F). Two changes were 
found in helix 8: 6 amino acids below the deficient mu- 
tation, a serine was changed in a threonine (S322T), and 
10 amino acids below the deficient mutation, a threon- 
ine was replaced by a glutamine (T326Q) (Fig. 1). Re- 
verse mutations in helix 8 (S322T and T326Q) are lo- 
cated on the same side on the helical wheel (Fig. 2). 
According to Brown et al. [7], this face of the helix 8 
may be oriented towards Cu, and form part of the 
proton channel into the binuclear centre. 
It will be of interest to investigate the revertants for 
their CO recombination kinetics. The question may be 
asked if the second site amino acid replacements, partic- 
ularly those located in helix 8, restore normal CO re- 
combination kinetics or if the respiratory deficiency can 
be compensated even if the CO recombination kinetics 
remain modified. The nature and position of the rever- 
sions present interesting properties: all changes led to an 
increase in the size of the compensatory amino acid 
without charge modification. The amino acids replace- 
ment responsible for the deficiency is located in the 
middle of the membrane whereas the compensatory 
amino acid changes are located near or at the inner side 
of the membrane. Four helices are involved in the com- 
pensation of the deficiency: reversions occur in helices 
5 and 8 which do not carry any binuclear centre ligands, 
and in the loop between helices 6 and 7, which carry the 
three Cu, ligands. 
In one revertant derived from the L53 mutant, the 
mutated amino acid (G352V) was replaced by an alan- 
ine (G > V > A). This replacement with a smaller amino 
acid was found to be able to restore the respiratory 
competence, suggesting that a minute steric difference 
between alanine and valine is critical for the function. 
Two long distance reversions were found: in the loop 
between helices 6 and 7, in position 267, a valine was 
replaced by a leucine (V256L) and in position 321, a 
phenylananine was changed into a leucine (F32 1 L). The 
compensatory mutation F321L is found to be located 
on the opposite side of the helix 8 helical wheel com- 
Table I 
Codon and amino acid replacements in COXl mutants and their revertants 
Strains Initial mutation locus Distant reversion locus Number of revertants and type 
of selection 
































































GTA z= ATA 
GTA > TTA 
TTA>TTT 
TCA > ACA 
CTG > CAG 
TCT > ACT 
GTA > TTA 
TTT>TTA 
ATT > GTT 
























A: independent spontaneous revertants 
B: independent mutagenesis 
C: revertants obtained from a mutagenized culture 
The types of selection were described in section 2. 
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Fig. 2. Localisation of amino acid substitutions in the mode1 of the cytochrome oxidase subunit I. The figure was based on the models proposed 
in [7] and [13]. Six of the 12 helices are presented Each helix is indicated as a helical wheel. H62 and H378, H376, H291 and H290 are the histidine 
ligands of, respectivaly, haem a, haem a3 and Cu,. The loop between helices 6 and 7, where are located the mutations S256T and V267M or L, 
is indicated by a dash line. The distant reversions of the deficiency mutations G253D (L13), D369N (L45), T316K (L29) and G352V (L53) are 
indicated by arrows. 
pared to the T316K (L29) mutation and its reversions, 
S322T and T326Q (Fig. 2). This may be correlated to 
the observation that mutant L53 (G352V) has normal 
CO recombination kinetics suggesting that unlike L29 
(T316K), the binuclear centre or its accessibility is not 
modified in L53. The effect of the lesion seems thus to 
be different in L53 and L29. The locations of these 
deficiency mutations and their distant reversions argue 
in favour of a functional and maybe a structural relation 
between helices 8, 9 and the connecting loop between 
helices 6 and 7. It is interesting that the same change at 
the same position, V267L, is able to compensate the 
deficiency of mutant L53 (G352V), carrying a mutation 
in helix 9, as well as that of mutant L29 (T316K), carry- 
ing a mutation within helix 8. 
Two long distant reversions, the replacement of an 
isoleucine by a valine in position 294 (1294V) and the 
replacement of a serine by an alanine in position 289 
(S289A), are compensatory to the L45 deficiency muta- 
tion (D369N) which is located in the loop connecting 
helices 9 and 10. This mutation is proximal to the haem 
a, ligand, histidine-376. Interestingly, the reversions are 
in close vicinity of the two Cu, ligands in helix 7. This 
represents an independent argument in favour of a top- 
ological proximity between helices 7 and 10 for the 
binuclear centre formation involving haem a, and Cur,. 
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